Where is the product shipped from?

The nearest ports for export are Guangzhou Port and Shenzhen Port.

Ha-11 Canine Leishmania Antibody Rapid Test C. Lsh Ab

Name: Ha-11 Canine Leishmania Antibody Rapid Test C. Lsh Ab
Brand: Guangzhou Herun Bio-Pharm Co., Ltd.
SKU: 2201321415

Guangdong, ChinaGuangzhou Herun Bio-Pharm Co., Ltd.

US$1.00-2.00

100 Pieces

Product profile

Customization

Available

Type

Detection Card

Syringe

Test Kit

Model NO.

HA-11

Blood Sampling Needle

Test Kit

Breathing Pattern

Test Kit

Animal Anesthesia Machine Control Method

Test Kit

Package

10t/20t/Box

Warranty

24 Months

Animals

Dog

Transport Package

Carton

Specification

1PC/Aluminum Foil Bag, 20PCS/Box.

Trademark

CHEMICOS

Origin

Guangzhou, China

HS Code

38220090

Production Capacity

100000 Pieces/Day

Key features

24 Months Warranty: Comprehensive 24-month warranty coverage for peace of mind.

OEM/ODM Support: Full OEM and ODM services available for custom requirements.

Easy Result Interpretation: Clear, easy-to-read outcomes for quick and confident decision-making.

High Precision Technology: Cutting-edge technology ensuring reliability and accuracy in every test.

Flexible Packaging Options: Available in 10t or 20t per box packaging configurations.

Low MOQ: Minimum Order Quantity is just 1 piece for easy trial orders.

Company profile

Exhibition ExperienceLow MOQCustomization from SamplesODM Services

Guangzhou Herun Bio-Pharm Co., Ltd.

Guangdong, China

Business Type: Manufacturer/Factory, Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedExport Year: N/A CertifiedNearest Port: Guangzhou Port, Shenzhen PortAverage Response Time: ≤9.56h CertifiedTerms of Payment: T/T

AI-Powered supplier vetting

SummaryThe supplier operates across services, forestry, animal husbandry and fishery, medical research, and sales of specialized medical, optical, agricultural, and testing equipment. It provides 3D design, ODM, OEM, SDK, and multiple customization services. Documented procedures exist for supplier assessment, corrective and preventive actions, and complaint handling, but quality assurance and raw-material traceability statuses are unknown. The supplier reports no new products in the past year and no inventory, overseas warehouse, or overseas showroom capability. Financial records are indicated for 2021–2023, but the provided data does not disclose performance results. Its company description emphasizes diagnostic products, protein-expression technology, R&D investment, and collaboration with universities and institutions.

Supplier typeThe supplier is a diversified service and technology-oriented company covering agricultural, forestry, animal husbandry and fishery, medical research, and specialized instrument and medical-device sales. Its stated focus on diagnostic products and solutions for human and animal health further indicates a life-science and healthcare-related supplier profile.

After-Sales capabilityThe supplier has a clear, documented complaint-handling procedure with implementation records and documented service-capability assessment procedures. However, no specific response scope, service network, or after-sales performance information is provided.

R&D capabilityThe supplier provides ODM services, OEM services for well-known brands, an available SDK, 3D design, and multiple design-customization options. Its description also cites product-development technology platforms, R&D investment, experienced scientists, and university or institutional collaboration; however, it launched no new products during the past year.

Customization capabilityThe supplier explicitly supports customization from samples, customization from designs, and full customization, along with 3D software design and ODM services. These statements provide direct evidence of broad product and design customization capability.